Holoclara

Los Angeles, United States

Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

$16.0M raised

Jun 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Holoclara raised?

Holoclara has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.

Who are Holoclara's investors?

Holoclara's investors include Kairos Ventures, Freeflow Ventures, Endurance28, Bold Capital Partners, Horizons Ventures.

Where is Holoclara headquartered?

Holoclara is headquartered in Los Angeles, United States.

What does Holoclara do?

Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

What stage is Holoclara at?

Holoclara is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2024.

MLA

"Holoclara — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/holoclara. Accessed July 8, 2026.

APA

VCBacked. (2024). Holoclara — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/holoclara

Wikipedia (cite web)

{{cite web |title=Holoclara — Funding & Investors |url=https://www.vcbacked.co/company/holoclara |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2024.